Price Alert

Immuron Limited (IMRN)

NASDAQ: IMRN · Real-Time Price · USD

1.89

-0.01 (-0.53%)

At close: Oct 01, 2025, 1:47 PM

-0.53% (1D)

Bid	1.86
Market Cap	10.76M
Revenue (ttm)	7.82M
Net Income (ttm)	-9.78M
EPS (ttm)	-0.6
PE Ratio (ttm)	-3.15
Forward PE	-96.25
Analyst	Buy
Dividends	n/a

Ask	1.92
Volume	14,056
Avg. Volume (20D)	241,620
Open	1.89
Previous Close	1.90
Day's Range	1.88 - 1.90
52-Week Range	1.50 - 2.75
Beta	0.50
Ex-Dividend Date	n/a

About IMRN

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol IMRN

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for IMRN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

8 months ago

+8.59%

Immuron shares are trading higher after the compan... Unlock content with Pro Subscription

8 months ago

+1.52%

Immuron shares are trading higher after the company announced that it has submitted its Phase 2 study report to the FDA and is preparing for the the next steps toward its Phase 3 trial.

News

2 years ago · newsfilecorp.com

Immuron Limited Announces Participation in the LD Micro Main Event XVI

Presentation on Wednesday, October 4th at 11:00 PT Melbourne, Australia--(Newsfile Corp. - September 18, 2023) - Immuron Limited (NASDAQ: IMRN), an Australian based and globally integrated biopharmace...

2 years ago · marketwatch.com

Immuron stock rockets after FDA removes hold on IND of infectious diarrhea treatment

The U.S.-listed shares of Immuron Ltd. IMRN powered up 66.3% toward a one-year high in premarket trading Monday, after the Australia-based biopharmaceutical company said the U.S. Food and Administrati...

2 years ago · proactiveinvestors.co.uk

Immuron CEO highlights strong sales growth in business update presentation

Immuron Ltd (NASDAQ:IMRN, ASX:IMC) CEO Steven Lydeamore highlighted the strong growth in sales of oral immunotherapeutic products in the company's February 2023 business update presentation for invest...

2 years ago · pennystocks.com

The Top Indicators That Penny Stocks Traders Use

Use these indicators for buying penny stocks in 2022 The post The Top Indicators That Penny Stocks Traders Use appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 years ago · seekingalpha.com

Immuron Limited (IMRN) Q4 2022 Earnings Call Transcript

Immuron Limited (NASDAQ:IMRN ) Q4 2022 Earnings Conference Call September 6, 2022 7:00 PM ET Company Participants Steven Lydeamore - Chief Executive Officer Conference Call Participants Unidentified C...

3 years ago · pennystocks.com

Best High Volume Penny Stocks to Watch Right Now

Check these three penny stocks out for your watchlist right now The post Best High Volume Penny Stocks to Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStoc...

3 years ago · investorplace.com

IMRN Stock Alert: What Is the Huge Catalyst Sending Immuron Soaring?

Today marks one of the best days for IMRN stock in a long time, with shares surging nearly 50% on the back of some impressive news. The post IMRN Stock Alert: What Is the Huge Catalyst Sending Immuron...

3 years ago · invezz.com

Here is why Immuron is up 30% on Wednesday

Immuron Limited (NASDAQ: IMRN) went up 30% after it announced that it had received $6.2 million from the Department of Defense to conduct clinical research on a dosing regimen for Travelan. This new ...

3 years ago · benzinga.com

Immuron Shares Rally On US Department Of Defense Funding Of A$6.2M

Immuron Limited (NASDAQ: IMRN) has received funding of A$6.2 ($4.45) million from the U.S Department of Defense to examine a dosing regimen for Travelan more suited for use by the military. The Compan...

3 years ago · pulse2.com

Immuron Stock (IMRN): Why The Price Surged Today

The stock price of Immuron (NASDAQ: IMRN) increased by over 80% pre-market today. This is why it happened.

Load More News